Skip to search formSkip to main contentSkip to account menu

eugenodilol

National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Eugenol
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Lipid solubility of vasodilatory vanilloid-type beta-blockers on the functional and binding activities of beta-adrenoceptor subtypes.
Various vanilloid-type beta-adrenoceptor blockers were studied on guinea pig right atrium and trachea and rat colon. In addition… 
1999
1999
Eugenodilol : A third-generation β-adrenoceptor blocker, derived from eugenol, with α-adrenoceptor blocking and β2-Adrenoceptor agonist-associated vasorelaxant activities
: Eugenodilol, derived from natural eugenol, was first investigated with in vivo and in vitro models. In our in vivo study… 
1999
1999
Eugenodilol: a third-generation beta-adrenoceptor blocker, derived from eugenol, with alpha-adrenoceptor blocking and beta2-adrenoceptor agonist-associated vasorelaxant activities.
Eugenodilol, derived from natural eugenol, was first investigated with in vivo and in vitro models. In our in vivo study… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)